About Danaher Corp. 
Danaher Corp.
Pharmaceuticals & Biotechnology
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.
Company Coordinates 
Company Details
2200 Pennsylvania Ave NW Ste 800w , WASHINGTON DC : 20037-1731
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 244 Schemes (34.6%)
Foreign Institutions
Held by 662 Foreign Institutions (20.97%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Steven Rales
Chairman of the Board
Mr. Rainer Blair
President, Chief Executive Officer, Director
Ms. Linda Hefner Filler
Lead Independent Director
Mr. Mitchell Rales
Director
Ms. Teri List-Stoll
Independent Director
Mr. Walter Lohr
Independent Director
Dr. Jessica Mega
Independent Director
Revenue and Profits:
Net Sales:
5,936 Million
(Quarterly Results - Jun 2025)
Net Profit:
555 Million
Pharmaceuticals & Biotechnology
USD 170,177 Million (Large Cap)
40.00
NA
0.50%
0.30
8.10%
3.25






